Back to search

Sweden· SE-20090627000013

Ribavirin Mylan 200 mg Kapsel, hård

A medicinal product containing ribavirin, registered in Sweden by Mylan S.A.S..

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedRibavirin Mylan 200 mg Kapsel, hårdATC—REGISTER NO.SE-20090627000013PACKS LISTED1CHECKEDAugust 27, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Ribavirin
Manufacturer
Mylan S.A.S.
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
August 27, 2026

Packs & prices · 1

  • se_varunummer
    20090627000013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ribavirin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ribavirin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Ribavirin Aurobindo
  • Germany · Ribavirin Ratiopharm
  • Spain · Ribavirina Normon
  • France · Ribavirine Pharmadev, Ribavirine Skyepharma
  • United Kingdom (Northern Ireland) · Ribavirin Milpharm
  • Italy · Ribavirina Aurobindo
  • Netherlands · Ribavirine Ratiopharm
  • Portugal · Ribavirina Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2e02651-900a-4166-ad26-9dc2eb272e4c
GET /v1/drugs/f2e02651-900a-4166-ad26-9dc2eb272e4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20090627000013",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20090627000013",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/ribavirin-mylan-epar-product-information_sv.pdf"
}

See everything about ribavirin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.